Skip to content

Three Quick Facts: Entain, Virgin Money and GSK

Three Quick Facts: Entain, Virgin Money and GSK

Three things you need to know in the financial markets today from investment writer, Tony Cross.

#1. Entain full year EBITDA upgraded off Q4 numbers

There’s a Q4 update out from Entain LON:ENT, which has posted a record period both in terms of net gaming revenue and active customer numbers. That’s lead to an upgrade in full year EBITDA forecasts by around 12% to just shy of £1 billion. Management note that the success has come off the back of global expansion and broadening customer appeal. Whilst they also note strong momentum is being carried into the new year, there’s no concern – or even acknowledgement – of pressures on discretionary spending.

#2. Virgin Money Q1 trading update shows solid uptick in lending deposits and margins

Virgin Money LON:VMUK has posted a Q1 trading update. Perhaps most crucially, the bank notes that arrears remain broadly stable across key leading segments, although bad debt provisions are being increased as the current situation appears below normal. Lending and deposits increased across the board, whilst net interest margin also advanced by three basis points as base rates tracked higher.

#3. GSK’s solid Q4 results put full year sales ahead of forecasts

Q4 numbers from Pharmaceuticals giant GSK LON:GSK impressed this morning, coming in ahead of analyst expectations. Full year sales were almost £30bn, up 13% on constant exchange rates, whilst total EPS more than doubled. The business is confident in terms of the outlook for FY23, with turnover expected to grow by a further 6%-8% and EPS to add 12% to 15%. Dividend payout forecasts for the year ahead remain unchanged.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.
Join our UK news channel on WhatsApp

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top